Endothelial nucleotide-binding oligomerization domain-like receptor protein 3 inflammasome regulation in atherosclerosis
Cardiovascular Research · 02.07.2024 · 120 (8) · 883-898
DOI: 10.1093/cvr/cvae071 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cardiovascular Research, online erschienen am 16.04.2024. Verfasst von Shuai Guo und 16 weiteren Autor:innen. Beteiligte Einrichtung: School of Basic Medical Sciences, State Key Lab of Respiratory Disease, Guangzhou Medical University, 195 Dongfeng W Rd, Yue Xiu Qu, Guang Zhou Shi, …. Hauptthemen laut MEDLINE: Phosphofructokinase-2, Atherosclerosis, Inflammasomes, NLR Family, Pyrin Domain-Containing 3 Protein. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 46 Literaturangaben. Gefördert von: Natural Science Foundation of China, National Key R&D Program of China, Sixth Affiliated Hospital of Guangzhou Medical University.
Abstract (Originalsprache)
Aims
The activation of nucleotide-binding oligomerization domain-like receptor protein 3 (NLRP3) inflammasome in endothelial cells (ECs) contributes to vascular inflammation in atherosclerosis. Considering the high glycolytic rate of ECs, we delineated whether and how glycolysis determines endothelial NLRP3 inflammasome activation in atherosclerosis. Methods and results Our results demonstrated a significant up-regulation of 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3 (PFKFB3), a key regulator of glycolysis, in human and mouse atherosclerotic endothelium, which positively correlated with NLRP3 levels. Atherosclerotic stimuli up-regulated endothelial PFKFB3 expression via sterol regulatory element-binding protein 2 (SREBP2) transactivation. EC-selective haplodeficiency of Pfkfb3 in Apoe−/− mice resulted in reduced endothelial NLRP3 inflammasome activation and attenuation of atherogenesis. Mechanistic investigations revealed that PFKFB3-driven glycolysis increased the NADH content and induced oligomerization of C-terminal binding protein 1 (CtBP1), an NADH-sensitive transcriptional co-repressor. The monomer form, but not the oligomer form, of CtBP1 was found to associate with the transcriptional repressor Forkhead box P1 (FOXP1) and acted as a transrepressor of inflammasome components, including NLRP3, caspase-1, and interleukin-1β (IL-1β). Interfering with NADH-induced CtBP1 oligomerization restored its binding to FOXP1 and inhibited the glycolysis-dependent up-regulation of NLRP3, Caspase-1, and IL-1β. Additionally, EC-specific overexpression of NADH-insensitive CtBP1 alleviates atherosclerosis.
Conclusion
Our findings highlight the existence of a glycolysis-dependent NADH/CtBP/FOXP1-transrepression pathway that regulates endothelial NLRP3 inflammasome activation in atherogenesis. This pathway represents a potential target for selective PFKFB3 inhibitors or strategies aimed at disrupting CtBP1 oligomerization to modulate atherosclerosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Basic Medical Sciences, State Key Lab of Respiratory Disease, Guangzhou Medical University, 195 Dongfeng W Rd, Yue Xiu Qu, Guang Zhou Shi, Guang Dong Sheng, China, 510180.
- Department of Cardiology, Shanghai Institute of Cardiovascular Diseases, Zhongshan Hospital, Fudan University, Shanghai, China.
- College of Basic Medicine, Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan, China.
- School of Pharmaceutical Sciences, Guangzhou Medical University, Guangzhou, China.
- Department of Neurosurgery, The People's Hospital of Qingyuan, The Sixth Affiliated Hospital of Guangzhou Medical University, Qingyuan, Guangdong, China.
- Department of Rehabilitation Center, The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China.
ORCID-Profile: Yuqing Huo, Yiming Xu
Förderung
- Natural Science Foundation of China
- National Key R&D Program of China
- Sixth Affiliated Hospital of Guangzhou Medical University
- Qingyuan People's Hospital
- Qingyuan People’s Hospital
Zitieren
APA
Guo, S., Wang, L., Cao, K., Li, Z., Song, M., Huang, S., Li, Z., Wang, C., Chen, P., Wang, Y., Dai, X., Chen, X., Fu, X., Feng, D., He, J., Huo, Y., & Xu, Y. (2024). Endothelial nucleotide-binding oligomerization domain-like receptor protein 3 inflammasome regulation in atherosclerosis. Cardiovascular Research, 120(8), 883-898. https://doi.org/10.1093/cvr/cvae071
Vancouver
Guo S, Wang L, Cao K, Li Z, Song M, Huang S, et al. Endothelial nucleotide-binding oligomerization domain-like receptor protein 3 inflammasome regulation in atherosclerosis. Cardiovascular Research. 2024;120(8):883-898. doi:10.1093/cvr/cvae071
BibTeX
@article{Guo2024,
author = {Guo, Shuai and Wang, Litao and Cao, Kaixiang and Li, Ziling and Song, Mingchuan and Huang, Shuqi and Li, Zou and Wang, Cailing and Chen, Peiling and Wang, Yong and Dai, Xiaoyan and Chen, Xianglin and Fu, Xiaodong and Feng, Du and He, Jun and Huo, Yuqing and Xu, Yiming},
title = {Endothelial nucleotide-binding oligomerization domain-like receptor protein 3 inflammasome regulation in atherosclerosis},
journal = {Cardiovascular Research},
year = {2024},
volume = {120},
number = {8},
pages = {883--898},
doi = {10.1093/cvr/cvae071}
}
EUVIMED